JP2013536865A5 - - Google Patents

Download PDF

Info

Publication number
JP2013536865A5
JP2013536865A5 JP2013527294A JP2013527294A JP2013536865A5 JP 2013536865 A5 JP2013536865 A5 JP 2013536865A5 JP 2013527294 A JP2013527294 A JP 2013527294A JP 2013527294 A JP2013527294 A JP 2013527294A JP 2013536865 A5 JP2013536865 A5 JP 2013536865A5
Authority
JP
Japan
Prior art keywords
propyl
methyl
hexadecyloxy
degrees
mono
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013527294A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013536865A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/050099 external-priority patent/WO2012031045A2/en
Publication of JP2013536865A publication Critical patent/JP2013536865A/ja
Publication of JP2013536865A5 publication Critical patent/JP2013536865A5/ja
Pending legal-status Critical Current

Links

JP2013527294A 2010-08-31 2011-08-31 ホスホン酸エステル誘導体およびその合成方法 Pending JP2013536865A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37874310P 2010-08-31 2010-08-31
US61/378,743 2010-08-31
PCT/US2011/050099 WO2012031045A2 (en) 2010-08-31 2011-08-31 Phosphonate ester derivatives and methods of synthesis thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015196930A Division JP2016094388A (ja) 2010-08-31 2015-10-02 ホスホン酸エステル誘導体およびその合成方法

Publications (2)

Publication Number Publication Date
JP2013536865A JP2013536865A (ja) 2013-09-26
JP2013536865A5 true JP2013536865A5 (https=) 2015-08-06

Family

ID=45771142

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2013527294A Pending JP2013536865A (ja) 2010-08-31 2011-08-31 ホスホン酸エステル誘導体およびその合成方法
JP2015196930A Pending JP2016094388A (ja) 2010-08-31 2015-10-02 ホスホン酸エステル誘導体およびその合成方法
JP2017110073A Pending JP2017214378A (ja) 2010-08-31 2017-06-02 ホスホン酸エステル誘導体およびその合成方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2015196930A Pending JP2016094388A (ja) 2010-08-31 2015-10-02 ホスホン酸エステル誘導体およびその合成方法
JP2017110073A Pending JP2017214378A (ja) 2010-08-31 2017-06-02 ホスホン酸エステル誘導体およびその合成方法

Country Status (11)

Country Link
US (3) US8569321B2 (https=)
EP (2) EP3020720B1 (https=)
JP (3) JP2013536865A (https=)
CN (3) CN105998039A (https=)
AU (1) AU2011295937B2 (https=)
BR (1) BR112013004925B1 (https=)
CA (1) CA2809679C (https=)
ES (2) ES2700117T3 (https=)
IL (4) IL224955A (https=)
RU (2) RU2581045C2 (https=)
WO (1) WO2012031045A2 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012031045A2 (en) * 2010-08-31 2012-03-08 Chimerix, Inc. Phosphonate ester derivatives and methods of synthesis thereof
SG10201800188SA (en) 2013-03-15 2018-02-27 Univ California Acyclic nucleoside phosphonate diesters
US8962829B1 (en) * 2013-11-15 2015-02-24 Chimerix, Inc. Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof
EP3077403A4 (en) * 2013-12-05 2017-08-02 Chimerix, Inc. Branched chain acyclic nucleoside phosphonate esters and methods of synthesis and uses thereof
CN103951703A (zh) * 2014-04-28 2014-07-30 中国人民解放军军事医学科学院微生物流行病研究所 制备膦酯衍生物的方法
CN111808136B (zh) 2014-09-15 2024-06-11 加利福尼亚大学董事会 核苷酸类似物
US10160778B2 (en) 2014-10-27 2018-12-25 Concert Pharmaceuticals, Inc. Pyrimidine phosphonic acid esters
EP3350191B9 (en) 2015-09-15 2021-12-22 The Regents of the University of California Nucleotide analogs
AU2017290703B2 (en) 2016-06-28 2023-03-30 Emergent Biodefense Operations Lansing Llc Formulations of brincidofovir
WO2020006050A1 (en) 2018-06-26 2020-01-02 Tsrl, Inc. Metabolically stable prodrugs
CN109021011A (zh) * 2018-08-14 2018-12-18 山东沾化永浩医药科技有限公司 一种合成对甲苯磺酰氧甲基膦酸二乙酯的方法
KR20250052378A (ko) 2022-07-21 2025-04-18 안티바 바이오사이언시즈, 인크. Hpv 감염 및 hpv-유도 신생물의 치료를 위한 조성물 및 투여 형태

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
JP3116079B2 (ja) * 1990-08-10 2000-12-11 インスティチュート オブ オーガニック ケミストリ アンド バイオケミストリ アカデミー オブ サイエンス オブ ザ チェコ リパブリック ヌクレオチドの新規な製法
JP2002528461A (ja) * 1998-10-23 2002-09-03 ダーウィン・ディスカバリー・リミテッド 公知ペプチドメタロプロテイナーゼインヒビターの単一形態型
CA2747954C (en) 1999-12-03 2014-02-25 The Regents Of The University Of California Phosphonate compounds
NZ543864A (en) * 2003-06-16 2009-10-30 Leuven K U Res & Dev Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs
JP2005045073A (ja) 2003-07-23 2005-02-17 Hamamatsu Photonics Kk 裏面入射型光検出素子
WO2005090370A1 (en) * 2004-02-05 2005-09-29 The Regents Of The University Of California Pharmacologically active agents containing esterified phosphonates and methods for use thereof
WO2005087788A2 (en) * 2004-03-04 2005-09-22 The Regents Of The University Of California Methods for preparation of nucleoside phosphonate esters
ES2401285T3 (es) * 2004-12-16 2013-04-18 The Regents Of The University Of California Fármacos con el pulmón como diana
US8642577B2 (en) * 2005-04-08 2014-02-04 Chimerix, Inc. Compounds, compositions and methods for the treatment of poxvirus infections
EP2842559A3 (en) 2005-04-08 2015-03-18 Chimerix, Inc. Compounds, compositions and methods for the treatment of viral infections and other medical disorders
WO2007130783A2 (en) * 2006-05-03 2007-11-15 Chimerix, Inc. Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates
AU2008246195B2 (en) * 2007-04-27 2014-06-05 Emergent Biodefence Operations Lansing Llc Methods of Reducing Nephrotoxicity in Subjects Administered with Nucleoside Phosphonates
WO2011011519A1 (en) 2009-07-21 2011-01-27 Chimerix, Inc. Compounds, compositions and methods for treating ocular conditions
CA2770282A1 (en) 2009-08-03 2011-02-10 Chimerix, Inc. Composition and methods of treating viral infections and viral induced tumors
CA2779473C (en) 2009-10-30 2016-08-16 Chimerix, Inc. Methods of treating viral associated diseases
US20110263536A1 (en) 2010-04-22 2011-10-27 Chimerix, Inc. Methods of Treating Orthopox Virus Infections and Associated Diseases
WO2012031045A2 (en) * 2010-08-31 2012-03-08 Chimerix, Inc. Phosphonate ester derivatives and methods of synthesis thereof
US20140303092A1 (en) * 2011-10-26 2014-10-09 Chimerix, Inc Hexadecyloxypropyl cidofovir for the treatment of double-stranded dna virus infection
WO2013163509A1 (en) * 2012-04-27 2013-10-31 Chimerix, Inc. A method of mitigating virus associated end-organ damage
US8962829B1 (en) * 2013-11-15 2015-02-24 Chimerix, Inc. Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof

Similar Documents

Publication Publication Date Title
JP2013536865A5 (https=)
AU2016271126B2 (en) Tetrasubstituted alkene compounds and their use
CA1339780C (en) Antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives
CN101218210B (zh) 罗苏伐他汀的制备方法和中间体
TWI642677B (zh) 非環狀核苷膦酸二酯
TWI666203B (zh) 製造嘧啶磺醯胺衍生物之方法
RU2013114370A (ru) Производные эфиров фосфоновых кислот и способы их синтеза
CN102295660A (zh) 泰诺福韦的合成工艺
CN104817593B (zh) 半富马酸替诺福韦艾拉酚胺关键中间体的合成工艺
CN112175003B (zh) 一种苯基氢膦酸酯及其中间体的制备方法
TW201623323A (zh) 替諾福韋前藥新多晶型及其製備方法和用途
WO2010086438A1 (en) Key intermediates for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof
JP2012523444A (ja) 内皮受容体アンタゴニスト(ボセンタン)を調製するための方法
JP6594333B2 (ja) Hx塩の形態の(e)−4−n,n−ジアルキルアミノクロトン酸の製造方法、およびegfrチロシンキナーゼ阻害剤の合成のためのその使用
CN109761884B (zh) 一种手性胺b的制备方法及其应用
EP3115367B1 (en) Intermediate compound for preparing rosuvastatin calcium and method for preparing rosuvastatin calcium therefrom
KR101832238B1 (ko) 신규한 설포닐옥시메틸포스포네이트 유도체 및 이를 이용한 다이아이소프로필 ((1-(트리틸옥시메틸)-사이클로프로필)옥시)메틸 포스포네이트의 제조방법
EP2800735B1 (en) Process for the preparation of fesoterodine
CN106674281A (zh) 一种瑞舒伐他汀中间体化合物、制备方法及其用途
WO2024249672A1 (en) Process of preparing hiv capsid inhibitor
RU2007104036A (ru) Способ получения диизопропил (гидроксиметил)-циклопропил)окси) метилфосфоната
JPH0273072A (ja) ヒドロキシメチルシクロブチルプリン類
CN116063233A (zh) 一种1h-咪唑-1-乙酸烃酯的制备方法
WO2015003589A1 (zh) 替诺福韦及其中间体的制备方法
JP2011526257A (ja) N−フェニル−n−(4−ピペリジニル)アミド塩の製造方法